Videos
A Conversation about Clostridia
Listen in as Jocelyn Strand, ND, Biocidin’s Director of Clinical Education, and Functional and Integrative Medicine expert Kurt Woeller, DO, discuss treatment strategies and effective protocols for using the Biocidin line of products with Clostridia species concerns.
2020 Research Overview
Biocidin® is committed to participating in ongoing research to better understand the activities of the botanicals in Biocidin® formulations and to generate data that advances the entire field of botanical medicine. In this webinar, we discuss the results of studies we have conducted and preview exciting research currently underway.
Impact of the Oral Microbiome on Systemic Health
Over 70% of the US population over 30 years old suffers from gingival or periodontal disease – the result of dysbiosis and the development of biofilms in the mouth. Oral dysbiosis has both local and systemic effects, resulting in immune dysregulation, pathogen translocation, inflammation, and more. Protocols with Biocidin® products offer gentle and effective solutions for disrupting biofilms and supporting microbial balance in the mouth.
Clostridia Bacterial Concerns Part 1: Pathogenicity Mechanisms
Clostridium difficile is labeled as one of the organisms of greatest concern for antibiotic resistance by the National Institutes of Health. It can also colonize the gastrointestinal tract, creating chronic symptoms that are harder to recognize. In this first installment of a three-part series, Kurt Woeller, DO discusses the breadth of symptoms that can manifest with Clostridium difficile and other pathogenic species.
Clostridia Bacterial Concerns Part 2: Laboratory Testing Options
Do you see symptoms in your patients that make you suspect Clostridium difficile (C. diff)? What’s the best way to confirm your suspicions? Kurt Woeller, DO, identifies the methods he finds most effective for detecting C. diff in patients, including both conventionally accepted as well as alternative techniques.
Clostridia Bacterial Concerns Part 3: Intervention Options
Once you’ve identified C. diff as the problem, what are the clinically effective therapeutics for addressing it? Longtime practitioner Kurt Woeller, DO, discusses conventional and alternative treatment methods and weighs the benefits and risks of each.
Part 1: The Microbiome: Short-Chain Fatty Acids and the LPS Connection
Do you wonder about the role that microbes play when you see conditions related to inflammation? In this series, Kristen Klos-Maki, DC, dives into the science that explains how overgrowth of harmful bacteria generates inflammation, and why inflammatory issues improve when we address microbiome and gut health.
Part 2: Systemic Disease and the LPS Connection
Now that we are aware of the microbiome, and its relationship to systemic inflammatory conditions, it becomes clear that regular evaluation of the microbiome is essential to achieve and maintain lasting therapeutic effects for our patients.
PART 3: The Role of Botanicals in Microbial Balance and Systemic Health
What if you could catch gut dysbiosis or increase microbial diversity before LPS became systemic and caused severe symptoms? Recent research supports the role botanicals play in producing short-chain fatty acids (SCFAs) and the modulation of gut microbiota composition, proving valuable tools to support patients with whole-body health.
New Approaches in Safety Protocols for Dental Procedures
Biological Dental Hygiene is a philosophy of care that promotes diagnosing root causes of dental disease, minimizing chemicals, and proactive prevention. In this 2020 presentation, Barbara Tritz, RDH, BS, MSB, presents innovative protocols that include Biocidin®TS. These protocols set the stage for safe and successful dental procedures.
Dysbiosis as a Root Cause of Inflammation
The microbiome – particularly in the mouth and GI tract – play a significant role in supporting health or predisposing us to disease. Join Dr. Jocelyn Strand, Biocidin’s Director of Clinical Education, as she discusses the research illuminating the importance of the microbiome in neurological health, and proven botanical therapies to restore microbiome balance.
Biocidin®LSF: Clinically Proven Botanicals + Advanced Liposomal Technology
When enhanced intracellular uptake is needed, practitioners appreciate the bioavailability of the liposomal delivery of Biocidin®. Listen in as Dr. Jocelyn Strand, Biocidin’s Director of Clinical Education, and Dr. Chris Shade, Founder and CEO of Quicksilver Scientific, discuss the marriage of clinically-proven botanicals and advanced liposomal technology.
Candidiasis Part I: Pathogenicity Mechanisms
Gastrointestinal candidiasis (GC) is well-known to functional and integrative medicine providers. In this article, Kurt Woeller, DO, discusses various aspects of chronic candidiasis as it relates to different health conditions and explores different mechanisms of pathogenicity including arabinose toxicity, leaky gut (intestinal permeability), invasive protein, and immune deficiency.
Candidiasis Part 2: Laboratory Testing Options
Blood cultures for Candida, unfortunately, are often unreliable. Based on years of clinical experience, Kurt Woeller, DO, outlines laboratory test options for the detection of intestinal candida, as well as effective methods for analyzing the invasive nature of these fungal organisms.
Candidiasis Part 3: Treatment Options
Invasive Candida. What can be done about it? Kurt Woeller, DO, discusses three distinct categories of intervention: systemic, non-systemic, and botanical. He specifically explores two antifungal medications and five botanicals known to be helpful in addressing chronic candidiasis.